KPV 10mg Anti-Inflammatory Tripeptide | Gut & Mucosal Research Peptide
KPV 10mg Anti-Inflammatory Tripeptide | Gut & Mucosal Research Peptide
KPV 10mg Anti-Inflammatory Tripeptide | Gut & Mucosal Research Peptide
Overview KPV is a synthetic tripeptide composed of lysine-proline-valine — the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). The 10mg presentation is engineered for advanced research into inflammatory signalling, mucosal biology, and gastrointestinal models, where its compact structure and stability offer distinct advantages over larger anti-inflammatory peptides.
Mechanism of Interest KPV retains the anti-inflammatory activity of its parent hormone (α-MSH) without engaging melanocortin receptors associated with pigmentation pathways. Research has explored its role in modulating NF-κB signalling, suppressing pro-inflammatory cytokines, and influencing immune cell behaviour at the cellular level. Its small molecular footprint allows for efficient cellular uptake and direct intracellular activity — making it a refined research tool in inflammation-focused models.
Product Specifications
- Product Name: KPV 10mg
- Catalogue Reference: KPV10-024
- Sequence: Lys-Pro-Val
- Molecular Formula: C₁₆H₃₀N₄O₄
- Molecular Weight: 342.43 g/mol
- Purity: ≥98% (HPLC verified)
- Presentation: Lyophilised solid
- Storage: -20°C
Research Applications KPV is widely utilised across gastrointestinal, dermatological, and immunological research — particularly in studies investigating colitis and inflammatory bowel models, mucosal barrier integrity, dermal inflammation, wound healing, mast cell modulation, and cytokine regulation. Its activity profile makes it a focused tool for research exploring localised and systemic inflammatory pathways.
Synergistic Research Context KPV is frequently studied alongside BPC-157 in dual-peptide gastrointestinal research models, where its anti-inflammatory action complements BPC-157's cytoprotective and angiogenic profile. This pairing represents one of the more refined combinations in gut-focused regenerative peptide research.
Quality & Handling Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure ≥98% purity, identity, and reproducibility.
Compliance Statement All Asclepius peptide products are supplied strictly for laboratory research purposes. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.
Order with Confidence Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.
For technical specifications, certificates of analysis, or research support, our team is available to assist.